BM
Brandywine Managers, LLC
13F filer · CIK 0001135121Reported Aug 14, 2026
13F portfolio value$202MU.S. long equity reported on 13F
Positions45Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight64.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202645 positions | |||||
| $74.1M | 36.68% | 1.12% | Not reported | Q3 2014 | |
| $24.8M | 12.25% | 0.01% | +1.0% | Q2 2019 | |
| $11M | 5.43% | Not reported | Not reported | Q2 2021 | |
| $3.96M | 1.96% | 0.01% | Not reported | Q3 2017 | |
| $3.04M | 1.50% | 0.00% | -19.5% | Q3 2018 | |
| $3.03M | 1.50% | 0.00% | -26.6% | Q3 2017 | |
| $2.63M | 1.30% | 0.01% | Not reported | Q3 2019 | |
| $2.62M | 1.30% | Not reported | +7.8% | Q2 2024 | |
| $2.16M | 1.07% | 0.03% | Not reported | Q4 2018 | |
| $2.12M | 1.05% | 0.00% | Not reported | Q1 2023 | |
| $2.01M | 1.00% | 0.05% | Not reported | Q1 2026 | |
| $1.63M | 0.81% | 0.00% | New | Q2 2026 | |
| $1.6M | 0.79% | 0.00% | Not reported | Q2 2018 | |
| $1.37M | 0.68% | 0.01% | Not reported | Q4 2018 | |
| $1.27M | 0.63% | 0.00% | Not reported | Q2 2022 | |
| $1.18M | 0.59% | 0.00% | Not reported | Q2 2024 | |
| $1.08M | 0.54% | 0.00% | Not reported | Q3 2020 | |
| $1M | 0.50% | Not reported | Not reported | Q4 2021 | |
| $917K | 0.45% | 0.00% | Not reported | Q2 2022 | |
| $874K | 0.43% | 0.02% | Not reported | Q1 2020 | |
| $868K | 0.43% | 0.01% | Not reported | Q1 2026 | |
| $834K | 0.41% | 0.00% | +11.3% | Q1 2026 | |
| $782K | 0.39% | 0.00% | New | Q2 2026 | |
| $743K | 0.37% | 0.00% | Not reported | Q1 2026 | |
| $726K | 0.36% | 0.01% | Not reported | Q3 2019 | |
| $719K | 0.36% | 0.02% | Not reported | Q3 2020 | |
| $717K | 0.35% | 0.01% | Not reported | Q3 2023 | |
| $698K | 0.35% | 0.00% | -26.8% | Q4 2018 | |
| $693K | 0.34% | 0.01% | New | Q2 2026 | |
| $690K | 0.34% | 0.05% | Not reported | Q1 2026 | |
| $666K | 0.33% | 0.00% | Not reported | Q4 2018 | |
| $656K | 0.32% | Not reported | Not reported | Q1 2026 | |
| $568K | 0.28% | 0.00% | New | Q2 2026 | |
| $486K | 0.24% | 0.00% | Not reported | Q1 2018 | |
| $480K | 0.24% | 0.00% | -35.0% | Q3 2017 | |
| $480K | 0.24% | 0.01% | Not reported | Q3 2024 | |
| $462K | 0.23% | 0.05% | Not reported | Q1 2020 | |
| $428K | 0.21% | 0.00% | -48.8% | Q2 2024 | |
| $383K | 0.19% | Not reported | Not reported | Q3 2017 | |
| $294K | 0.15% | 0.04% | Not reported | Q2 2019 | |
| $294K | 0.15% | 0.01% | -40.2% | Q3 2025 | |
| $275K | 0.14% | 0.21% | New | Q2 2026 | |
| $262K | 0.13% | Not reported | Not reported | Q4 2024 | |
| $256K | 0.13% | 0.02% | New | Q2 2026 | |
| $224K | 0.11% | 0.01% | Not reported | Q4 2020 | |
| Q1 2026Reported May 14, 202639 positions | |||||
| $74.1M | 43.64% | 1.12% | Not reported | Q3 2014 | |
| $12.5M | 7.38% | 0.01% | -0.7% | Q2 2019 | |
| $11.2M | 6.60% | Not reported | Not reported | Q2 2021 | |
| $3.29M | 1.94% | 0.00% | -2.8% | Q3 2018 | |
| $2.92M | 1.72% | 0.01% | -6.4% | Q3 2017 | |
| $2.11M | 1.24% | 0.00% | Not reported | Q1 2023 | |
| $2.04M | 1.20% | Not reported | Not reported | Q2 2024 | |
| $1.44M | 0.85% | 0.00% | Not reported | Q3 2017 | |
| $1.29M | 0.76% | 0.00% | Not reported | Q3 2020 | |
| $1.19M | 0.70% | 0.01% | Not reported | Q3 2019 | |
| $1.05M | 0.62% | 0.00% | -12.4% | Q4 2018 | |
| $996K | 0.59% | 0.03% | Not reported | Q4 2018 | |
| $981K | 0.58% | Not reported | Not reported | Q4 2021 | |
| $892K | 0.52% | 0.00% | Not reported | Q2 2022 | |
| $862K | 0.51% | 0.00% | Not reported | Q2 2024 | |
| $857K | 0.50% | 0.00% | -14.7% | Q3 2017 | |
| $854K | 0.50% | 0.05% | New | Q1 2026 | |
| $844K | 0.50% | 0.01% | -9.9% | Q4 2018 | |
| $752K | 0.44% | 0.00% | Not reported | Q2 2022 | |
| $752K | 0.44% | 0.00% | Not reported | Q2 2018 | |
| $644K | 0.38% | 0.01% | Not reported | Q3 2023 | |
| $641K | 0.38% | 0.00% | Not reported | Q2 2024 | |
| $631K | 0.37% | 0.01% | New | Q1 2026 | |
| $609K | 0.36% | 0.00% | New | Q1 2026 | |
| $607K | 0.36% | 0.02% | +36.8% | Q1 2020 | |
| $593K | 0.35% | 0.00% | New | Q1 2026 | |
| $533K | 0.31% | Not reported | New | Q1 2026 | |
| $483K | 0.28% | 0.00% | Not reported | Q4 2018 | |
| $454K | 0.27% | 0.05% | New | Q1 2026 | |
| $408K | 0.24% | 0.02% | Not reported | Q3 2025 | |
| $402K | 0.24% | 0.01% | Not reported | Q3 2019 | |
| $400K | 0.24% | 0.01% | Not reported | Q3 2024 | |
| $382K | 0.23% | 0.02% | Not reported | Q3 2020 | |
| $338K | 0.20% | Not reported | Not reported | Q4 2024 | |
| $323K | 0.19% | 0.05% | +36.2% | Q1 2020 | |
| $297K | 0.17% | 0.00% | Not reported | Q1 2018 | |
| $221K | 0.13% | Not reported | -28.1% | Q3 2017 | |
| $190K | 0.11% | 0.04% | Not reported | Q2 2019 | |
| $99.4K | 0.06% | 0.01% | Not reported | Q4 2020 | |
| Q4 2025Reported Feb 13, 202637 positions | |||||
| $92.8M | 45.88% | 1.12% | Not reported | Q3 2014 | |
| $16.5M | 8.18% | Not reported | Not reported | Q2 2021 | |
| $15.2M | 7.50% | 0.01% | -0.3% | Q2 2019 | |
| $3.62M | 1.79% | 0.00% | -1.0% | Q3 2018 | |
| $3.57M | 1.77% | 0.01% | -1.3% | Q3 2017 | |
| $2.4M | 1.19% | 0.00% | Not reported | Q1 2023 | |
| $1.95M | 0.97% | Not reported | Not reported | Q2 2024 | |
| $1.88M | 0.93% | 0.01% | Not reported | Q4 2018 | |
| $1.83M | 0.91% | 0.00% | Not reported | Q3 2020 | |
| $1.52M | 0.75% | 0.00% | Not reported | Q3 2017 | |
| $1.48M | 0.73% | 0.00% | Not reported | Q2 2024 | |
| $1.44M | 0.71% | 0.00% | -2.7% | Q4 2018 | |
| $1.37M | 0.68% | 0.01% | Not reported | Q3 2019 | |
| $1.23M | 0.61% | 0.00% | -4.4% | Q3 2017 | |
| $1.1M | 0.54% | Not reported | Not reported | Q4 2021 | |
| $1.09M | 0.54% | 0.00% | Not reported | Q2 2022 | |
| $1.03M | 0.51% | 0.01% | -1.0% | Q4 2018 | |
| $1.02M | 0.50% | 0.00% | Not reported | Q2 2022 | |
| $929K | 0.46% | 0.01% | +20.8% | Q3 2023 | |
| ABRNAMAvidity Biosciences, Inc. | $905K | 0.45% | 0.01% | Not reported | Q3 2025 |
| $749K | 0.37% | 0.00% | Not reported | Q2 2024 | |
| $684K | 0.34% | 0.00% | Not reported | Q4 2016 | |
| $665K | 0.33% | 0.03% | Not reported | Q4 2018 | |
| $640K | 0.32% | Not reported | +18.3% | Q3 2025 | |
| $616K | 0.30% | 0.00% | Not reported | Q2 2017 | |
| $564K | 0.28% | Not reported | Not reported | Q4 2024 | |
| $516K | 0.26% | 0.02% | Not reported | Q1 2020 | |
| $489K | 0.24% | 0.02% | Not reported | Q3 2025 | |
| $433K | 0.21% | 0.01% | Not reported | Q3 2024 | |
| $400K | 0.20% | 0.03% | Not reported | Q2 2019 | |
| $373K | 0.18% | 0.03% | Not reported | Q1 2020 | |
| $338K | 0.17% | Not reported | -7.1% | Q3 2017 | |
| $335K | 0.17% | 0.00% | Not reported | Q1 2018 | |
| $325K | 0.16% | 0.02% | Not reported | Q3 2020 | |
| $309K | 0.15% | 0.01% | Not reported | Q3 2019 | |
| $280K | 0.14% | 0.00% | Not reported | Q4 2018 | |
| $97.4K | 0.05% | 0.01% | Not reported | Q4 2020 | |
| Q3 2025Reported Nov 14, 202536 positions | |||||
| $15.9M | 15.27% | 0.01% | -1.1% | Q2 2019 | |
| $13.5M | 12.96% | Not reported | Not reported | Q2 2021 | |
| $3.66M | 3.51% | 0.00% | -3.5% | Q3 2018 | |
| $2.88M | 2.76% | 0.00% | Not reported | Q1 2023 | |
| $2.54M | 2.44% | 0.01% | -11.5% | Q3 2017 | |
| $2.5M | 2.40% | 0.01% | Not reported | Q4 2018 | |
| $2.13M | 2.04% | Not reported | Not reported | Q2 2024 | |
| $1.7M | 1.63% | 0.00% | -11.9% | Q4 2018 | |
| $1.64M | 1.57% | 0.00% | Not reported | Q3 2020 | |
| $1.44M | 1.38% | 0.01% | Not reported | Q3 2019 | |
| $1.15M | 1.11% | Not reported | Not reported | Q4 2021 | |
| $1.15M | 1.10% | 0.00% | Not reported | Q3 2017 | |
| $1.13M | 1.08% | 0.00% | Not reported | Q2 2022 | |
| $1.09M | 1.05% | 0.00% | -14.6% | Q2 2024 | |
| $1.02M | 0.98% | 0.00% | -28.3% | Q3 2017 | |
| $1.02M | 0.97% | 0.00% | Not reported | Q2 2022 | |
| $822K | 0.79% | 0.00% | Not reported | Q2 2017 | |
| $822K | 0.79% | 0.00% | Not reported | Q4 2016 | |
| $751K | 0.72% | Not reported | New | Q3 2025 | |
| $639K | 0.61% | 0.01% | Not reported | Q4 2018 | |
| $590K | 0.57% | 0.03% | Not reported | Q4 2018 | |
| $565K | 0.54% | 0.02% | New | Q3 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $546K | 0.52% | 0.01% | New | Q3 2025 |
| $532K | 0.51% | 0.00% | Not reported | Q2 2024 | |
| $504K | 0.48% | 0.03% | Not reported | Q2 2019 | |
| $481K | 0.46% | Not reported | +33.3% | Q4 2024 | |
| $452K | 0.43% | 0.02% | Not reported | Q1 2020 | |
| $419K | 0.40% | 0.03% | Not reported | Q1 2020 | |
| $386K | 0.37% | Not reported | -59.2% | Q3 2017 | |
| $323K | 0.31% | 0.01% | +52.2% | Q3 2024 | |
| $310K | 0.30% | 0.01% | Not reported | Q3 2023 | |
| $246K | 0.24% | 0.00% | Not reported | Q4 2018 | |
| $236K | 0.23% | 0.00% | Not reported | Q1 2018 | |
| $221K | 0.21% | 0.02% | Not reported | Q3 2019 | |
| $201K | 0.19% | 0.02% | Not reported | Q3 2020 | |
| $143K | 0.14% | 0.01% | Not reported | Q4 2020 | |
Premium opens every quarter this fund has filed